Cambrex’s Post

🔍 Join SCHOTT MINIFAB for an insightful webinar where the expert speakers will explore the latest applications in diagnostics and drug discovery. Learn about the critical build vs. buy decision for microarray production, focusing on infrastructure, expertise, and equipment considerations. Key takeaways: 🔸 Understanding the build vs. buy dilemma for microarray products 🔸 Making better-informed decisions on microarray production 🔸 Leveraging collaborations to reduce time-to-market and mitigate launch risks ➡️ Learn more + register here: https://buff.ly/3KQw7iG #MedicalDevice #DrugDiscovery #IVD #LaboratoryTechnology #CommercialManufacturing #InVitroDiagnostics #SupplyChain

What is the impact of in-solution kinetics on drug discovery? If you missed the talk by Henrik Jensen, you can still learn more from our on demand webinar here: https://lnkd.in/dxndKmyR

📢 Join AustinPx for an upcoming webinar to explore the growing role of amorphous solid dispersions (#ASD) in drug development, driven by the increase in poorly soluble molecules. With next-gen technologies like KinetiSol™ setting new benchmarks for scalability and performance, this session will dive into overcoming common scale-up challenges. The featured speakers will share their experiences with technology transfers, best practices for scale-up, and how to enhance the manufacturability of ASDs. Gain insights into improving tech transfer processes and ensuring successful commercialization. ➡️ REGISTER HERE: https://buff.ly/3XBy5dO 🌟 Featured speakers: Justin Keen TJ Higley #DrugDevelopment #PharmaceuticalManufacturing #DrugManufacturing #AmorphousSolidDispersions #CommercialManufacturing #APIFormulationDevelopment

In a rapidly evolving #biotech landscape, strategic partnerships are paramount. Recent congressional scrutiny surrounding a major firm's involvement in U.S. pharmaceuticals underscores the importance of choosing the right #laboratory partner. As lawmakers raise national security concerns and seek to disengage from certain entities, it's crucial to recognize the potential impact on drug and device development pipelines. https://lnkd.in/g2XDBvsw For our part, US-based iuvo Bioscience continues to serve the medical device and pharmaceutical industry through exquisite science and providing exceptional service. Our commitment to excellence ensures that projects are not only propelled forward but also shielded from external uncertainties. By choosing iuvo as your laboratory partner, you gain access to a team dedicated to upholding the highest standards of quality and compliance. As the biotech industry navigates shifting dynamics, iuvo BioScience remains steadfast in our mission to empower innovation. Let's collaborate to drive breakthrough discoveries forward while safeguarding the integrity of your projects. Reach out today and discover the iuvo difference! #BiotechInnovation #DrugDevelopment #Partnership #Trust #Innovation #iuvoBioscience; Ben Burton; David Kudla, MBA; Shannon Stoddard; Scott Barnhill; BioSpace; Sanjeev Ganatra; #preclinicalresearch; #clinicalresearch; Biotechnology Innovation Organization; Empire State Development; NewYorkBIO https://lnkd.in/gbviMKKt

XtalPi's drug discovery capabilities streamline every step, from library design and synthesis to compound delivery. In these two new case studies, our team shares how we accomplished this rapidly (in less than a week) for recent projects. Click here to read the case studies now: https://hubs.li/Q02yYyTg0 #librarysynthesis #compounddelivery #librarydesign #drugdiscovery

📢 Today, we're at the BioTechX event in Switzerland. Speak to Ahmed EL-RAYIS, PhD if you would like to book a meeting to discuss how MDC can help support your drug discovery project. #DrugDiscovery

On World #IntellectualProperty day we re-launched the Incubate Coalition policy lab with a simple explanation of the biopharma patent system and by challenging myths and misconceptions about patent thickets, post market clinical trials and generic competition, John Stanford

Thoughts on this? >> ProMIS announces PIPE up to $122M; Confo raises €60M in Series B >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #productmarketing #biotech

In Part One of Serán BioScience's two-part video series, Dr. Wesley Tatum covers key considerations for ASD product development. Formulation development of ASDs focuses on polymer selection, the ratio of drug to polymer, and the design of the ASD particles to develop a system that is physically stable while also demonstrating optimal performance. In this presentation, Dr. Tatum will cover some of the philosophies and principles used to guide ASD product formulation. Learn more and watch on-demand here: https://hubs.li/Q02vsfcK0 #amorphousdispersion #ASD #drugdevelopment

Thoughts on this? >> ProMIS announces PIPE up to $122M; Confo raises €60M in Series B >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical